MIMRELSA
"MIMRELSA" is a word mark owned by Protagonist Therapeutics, Inc., filed at the USPTO on November 29, 2022. It has been allowed and covers classes 5, 42 and 44.
- Status
- Allowed
- Since July 22, 2026
- Filed
- November 29, 2022
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 97696650
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 3 classes
Who owns MIMRELSA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Protagonist Therapeutics, Inc.
PTGX · Newark, United States
Representative
Melissa A. Nowak
Christensen O'Connor Johnson Kindness
What the mark covers
The products and services MIMRELSA is filed for, grouped by Nice class.
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders
Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of approval of extension request e-mailed
- Sou extension 5 granted
- Case assigned to intent to use paralegal
- Sou extension 5 filed
- Sou teas extension received
- Teas withdrawal of attorney received-firm retains
- Teas change of correspondence received
- Attorney/dom.rep.revoked and/or appointed
- Teas revoke/app/change addr of atty/dom rep received
- Notice of approval of extension request e-mailed
10 earlier steps on the official record.
About MIMRELSA
Who owns the trademark "MIMRELSA"?
The USPTO trademark "MIMRELSA" (application 97696650) is owned by Protagonist Therapeutics, Inc.
What is the status of "MIMRELSA"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull MIMRELSA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b27-6b6f-728d-8acb-05a91bd16828
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b27-6b6f-728d-8acb-05a91bd16828",
"object": "trademark",
"mark_text": "MIMRELSA",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "97696650",
"filing_date": "2022-11-29",
"nice_classes": [
5,
42,
44
],
"owners": [
{
"name": "Protagonist Therapeutics, Inc.",
"entity_id": "ent_019eb715-aaa5-750e-ab80-0f081fc9e674"
}
]
}